Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indian Pharmas Threaten Production Halt If Price Increases Barred

This article was originally published in PharmAsia News

Executive Summary

Indian pharmaceuticals are threatening to stop making certain drugs if the government does not allow price increases. B.N. Singh, president of the Indian Drug Manufacturers' Association, said his group has appealed to the Ministry of Chemicals and Fertilisers to be allowed to raise prices to reflect the higher cost of bulk drugs and packaging materials. The IDMA also says Indian drug makers face increased costs of freight and accommodation and can no longer absorb them. The group cites the recent substantial increase in the cost of bulk drugs imported from China. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067592

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel